» Articles » PMID: 25707584

Tissue Reaction to Porcine Intestinal Submucosa (CorMatrix) Implants in Pediatric Cardiac Patients: a Single-center Experience

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2015 Feb 25
PMID 25707584
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Decellularized porcine small intestine submucosa (CorMatrix, Atlanta, GA) patches have been used in the repair of congenital heart malformations. Tissue reaction to the material may create hemodynamic dysfunction and necessitate explantation. We reviewed our series of congenital cardiac patients who had a reoperation after the implantation of CorMatrix patches.

Methods: Medical records of pediatric cardiac patient who received CorMatrix patches and those of patients who underwent reoperation were reviewed. Routine histologic sections of explanted CorMatrix specimens were examined.

Results: Of 25 patients who had received CorMatrix patches during cardiac operations at our institution, 6 patients had undergone reoperations. All patients had hemodynamically significant lesions at the site of the CorMatrix implantation. Explanted specimens were associated with an intense inflammatory reaction consisting of numerous eosinophils, histiocytes, and plasma cells, with accompanying granulation tissue and fibrosis.

Conclusions: Reaction to implanted CorMatrix patches may cause hemodynamic dysfunction and produce an intense, predominantly eosinophilic inflammatory response with developing fibrosis. Although our report is limited to a small sample of congenital cardiac patients, one should take precautions in its use in pediatric cardiac patients, and long-term follow-up is warranted.

Citing Articles

An Characterization of a PCL-Fibrin Scaffold for Myocardial Repair.

Jarrell D, Jacot J Mater Today Commun. 2023; 37.

PMID: 38130877 PMC: 10732481. DOI: 10.1016/j.mtcomm.2023.107596.


Patch Materials for Pulmonary Artery Arterioplasty and Right Ventricular Outflow Tract Augmentation: A Review.

Schwartzman W, Jimenez M, Yates A, Armstrong A, Salavitabar A, Hor K Pediatr Cardiol. 2023; 44(5):973-995.

PMID: 37149833 PMC: 10224813. DOI: 10.1007/s00246-023-03152-7.


Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications.

Palmosi T, Tolomeo A, Cirillo C, Sandrin D, Sciro M, Negrisolo S Front Bioeng Biotechnol. 2022; 10:1042434.

PMID: 36578513 PMC: 9792098. DOI: 10.3389/fbioe.2022.1042434.


Extracellular Matrix-Based Approaches in Cardiac Regeneration: Challenges and Opportunities.

Vu T, Lorizio D, Vuerich R, Lippi M, Nascimento D, Zacchigna S Int J Mol Sci. 2022; 23(24).

PMID: 36555424 PMC: 9779713. DOI: 10.3390/ijms232415783.


Results of mitral valve reconstruction using substitute extracellular matrix.

Arbona M, David T, David C, Rao V JTCVS Tech. 2022; 16:43-48.

PMID: 36510520 PMC: 9735417. DOI: 10.1016/j.xjtc.2022.09.014.